Stocks Health care TLSA
NASDAQ · Health careTiziana Life Sciences Ltd (TLSA)
It posted a net loss of $11.9M. In fiscal 2024 capital spending exceeded operating cash flow by $1.5M. At December 31, 2024 it held $3.7M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on May 1, 2026.
What Tiziana Life Sciences Ltd does
Tiziana Life Sciences Ltd is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker TLSA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2024 | n/a | -$11.9M | -$0.11 | -$1.5M |
| 2023 | n/a | -$17.7M | -$0.17 | n/a |
| 2022 | n/a | -$15.4M | -$0.15 | n/a |
| 2021 | n/a | -$23.4M | -$0.24 | -$21.8M |
| 2020 | n/a | -$26.1M | -$0.16 | -$11.3M |
| 2019 | n/a | -$9.3M | -$0.07 | -$6.8M |
Latest SEC filings
What Tiziana Life Sciences Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 21, 2026
- September 17, 2026
- August 24, 2026
- August 6, 2026
- August 4, 2026
- July 31, 2026
- July 22, 2026
- June 25, 2026
- June 15, 2026
- May 28, 2026
Questions about TLSA
What does Tiziana Life Sciences Ltd do?
Tiziana Life Sciences Ltd is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker TLSA.
Is Tiziana Life Sciences Ltd profitable?
No. In fiscal 2024 it reported a net loss of $11.9M.
When did Tiziana Life Sciences Ltd last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on May 1, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 21, 2026.
Similar companies
Follow TLSA
Get an email when Tiziana Life Sciences Ltd files with the SEC: results, executive changes, material agreements and annual reports.
Follow TLSA: get an email when it filesWhere the numbers come from
Financial figures are the values Tiziana Life Sciences Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.